Diabetes and gout: efficacy and safety of febuxostat and allopurinol. [electronic resource]
Producer: 20140527Description: 1049-55 p. digitalISSN:- 1463-1326
- Adult
- Aged
- Aged, 80 and over
- Allopurinol -- administration & dosage
- Body Mass Index
- Cohort Studies
- Comorbidity
- Diabetes Complications -- blood
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- administration & dosage
- Febuxostat
- Female
- Gout -- blood
- Gout Suppressants -- administration & dosage
- Humans
- Intention to Treat Analysis
- Kidney -- physiopathology
- Lost to Follow-Up
- Male
- Middle Aged
- Obesity -- epidemiology
- Patient Dropouts
- Renal Insufficiency -- epidemiology
- Thiazoles -- administration & dosage
- Xanthine Oxidase -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.